Lewes, DE -- (SBWire) -- 09/07/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Francesca's Holdings Corp (NASDAQ:FRAN), Discovery Laboratories, Inc. (NASDAQ:DSCO), GenVec Inc (NASDAQ:GNVC), Merrimack Pharmaceuticals Inc (NASDAQ:MACK).

Francesca's Holdings Corp (NASDAQ:FRAN) decreased -1.72% and closed at $18.05 on a traded volume of 2.00 million shares, in comparison to 1.81 million shares of average trading volume. So far this year, the stock is down over -27.57%.

The company has a total market capitalization of $796.00 million and its total outstanding shares are44.10 million.

Will FRAN Get Buyers Even After The Recent Rally? Find Out Here

Francesca's Holdings Corporation, through its subsidiary, Francesca’s Collections, Inc., operates a chain of retail boutiques.

Discovery Laboratories, Inc. (NASDAQ:DSCO) soared 12.50% and closed at $1.98 on a traded volume of 1.97 million shares, whereas its average trading volume is 257.548 shares. In the last three months, the stock is up 11.86%. The Intra-day range for the stock is $1.76 and $1.98.

Will DSCO Continue To Move Higher? Find Out Here

Discovery Laboratories, Inc., a specialty biotechnology company, focuses on developing products for critical care patients with respiratory disease and care in pulmonary medicine.

GenVec Inc (NASDAQ:GNVC) jumped 59.71% and closed at $0.639. So far in three months, the stock is up 59.71%. The 52-week range for the stock is $0.25 and $2.20 and during the previous trading session the stock touched its highest price at $0.64. Its introductory price for the day was $0.43, with the overall traded volume of 1.95 million shares.

Will GNVC Continue To Move Higher? Find Out Here

GenVec, Inc. operates as a biopharmaceutical company that uses differentiated and proprietary technologies to create therapeutics and vaccines.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) after opening its trade at the price of $3.86, jumped 4.20% to close at $3.97 for the day. The stock moved on a traded volume of 1.92 million shares, in comparison to 2.02 million shares of average trading volume.

The 52-week range for the stock is $3.26 and $11.11 and during the previous trading session the stock touched its highest price at $4.05.

Will MACK Continue To Move Higher? Find Out Here

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States.

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/